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Excretion of Amphetamines in Human Sweat
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Department of Pharmacology, Catholic University of Nijmegen, The Netherlands
A bstract— Amphetamine-Iike compounds are excreted in swéat of 
hum an subject whose sweat production was stimulated by forced labor. 
T h is excretion is largely independent on sweat pH . Analysis of sweat 
may therefore be used in doping control.
Introduction
Electrolytes present in the blood, as sodium, chloride, bromide, iron, are to 
the same extend excreted by the sweat gland (1, 2). Alsö various organic com­
pounds as urea and mucus are present in human sweat (3, 4). Several exogenous 
compounds as sulphonamide, hexamine, bromide are excreted by the sweat 
gland (5).
Sweat originates from the bloodplasma while its composition is mainly 
determined by reabsorption and exchange mechanisms (8). The pH of'sweat may 
difïer considerably in different individuals (1). The production of. sweat and 
urine are to some extend related processes. It is therefore of importance to do a 
comparative study on the excretion of amphetamines in sweat and urine.
Since athletes, cyclists etc. produce a large amount of sweat, a doping control 
could also be done by analysis of sweat, provided that the doping agents are 
excreted in sweat.
Methods
L-dimethylamphetamine HC1, in contrast to D-dimethyl-amphetamine, a 
relative non-toxic, non-stimulating amphetamine, was given to healthy subjects 
as an oral dose of 20-25 mg. Sweating was stimulated at regular intervals follow- 
ing ingestion of the drug by letting the subjects make exercises on a bicycle 
ergometer (Table I). During 10 min of sweating, sweat was rapidly collected 
from the forehead and the back of the subject. In each sweat trial 3-10 ml sweat 
were collected. Simultaneously the urine was collected for a pèriod of 60 hr.
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H
Subject Tim e1
(hr)
ml Sweat2
PH
fig/ml
Weight3
Loss
(kg)
W att1 Rotations5 Tim e of6 
. excretion
L-m eth-
amphetamine
L-dimethyl-
amphetamine
T,V. 1.30 1 0 4.85 0.118 1.38 0.600 150 80 2 0  min
dose 5.30 8 4.70 0.75 4.27 0.274 150 80 2 0
2 0  mg 8.30 8 4.65 0.50 2 . 6 6 0 . 2 1 0 150 80 2 085 kg 25.25 7 4.70 0.21 0.33 0.235 150 80 2 0
32.00 7 4.60 0.19 0.29 0.230 150 80 2 0
54.00 7 4.50 0.04 -— 0.230 150 80 2 0
C.G. 3.10 3 6.90 0.25 2.50 0 . 2 0 0 150 80 25 min
dose 7.00 3 7.35 0.33 2.70 0 . 2 0 0 150 80 25
25 mg 24.00 4 7.50 0.17 0.49 0.180 150 80 25
80 kg 28.00 5 7.80 0.07 0.16 0.240 150 80 25
1 Tim e after ingestion of the drug. 2 T he sweat pH  is measured in the collected sweat. 3 Weight loss of the subject during the excersise. 
4 Load of the bicycle ergometer. 8 Velocity of bicycle ergometer. 6 Tim e course of sweat product ion.
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L-dimethylamphetamine and its possible metabolite, L-methamphetamine, 
were determined quantitatively by gas-liquid chromatography (Fig. 1). For 
details is referred to Vree et al. (6, 7).
F i g . 1
Gaschromatogram of urine and sweat extract.
Compound 1 is the internal Standard (10 fig), compound 2 represents the metabolite 
L-amphetamine, compound 3 the metabolite L-methamphetamine and compound 4 
represents L-dimethylamphetamine.
T he urine sample V19 is taken 30 h r after the intake of 20 mg of L-dimethylamphetam- 
ine HC1. T he sweat sample VZ5 is taken 32 h r  after the ingestion of the drug.
The identity of the parent drug and its metabolite was checked by analysis 
of mass-spectra by using the combined gaschromatograph-mass-spectrometer 
(L.K.B. 9000). Typical mass-spectra are given in Fig. 2 and 3. Characteristic 
for dimethyl-amphetamine is the base peak of mass 72 and for the metabolite 
methamphetamine that if mass 58.
Typical excretion curves both with respect to urine and sweat are presented in 
Fig. 4.
Results and Discussion
L-dimethylamphetamine, as well as its metabolite L-methamphetamine, is 
excreted in sweat of human subjects (Fig. 4). Following ingestion of 20-25 mg 
of this amphetamine analogue, the maximum concentration in sweat is in the
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order of 2-4 mg/ml. The concentration of these drugs in sweat increases during 
the first few hours after ingestion, while from 6 hr on there is a gradual decrease 
of the concentration. The concentration of the parent drug and its metabolite in
F i g . 2
M ass-spectra of L-dimethylamphetamine and L-methamphetamine. The mass-spec- 
trum  of L-dimethylamphetam ine as reference compound is identical with thè mass- 
spectrum  of the compound extracted from the sweat. T he same holds for the metabolite 
L-methamphetamine.
sweat parallels the rate of excretion in the urine. The concentration of dimethy- 
lamphetamine in the sweat of subject C.G., 7 hr after ingestion, was 2.7 fig/ml 
(Table I), while in the urine the average concentration during the period 5 hr 
after injection was 2.88 /Ag/ml. At that time the pH of the sweat was 7.35, while 
the pH of the urine then was 5.30. So although the pH of the two fluids differ by 
2 pH units, the concentration of the amphetamine is in the same order of magni­
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tude. Both subjects received ammoniumchloride ih order to keep the pH of 
the urine around pH =  5. Nevertheless, in the one subject the sweat pH re- 
mained high (Fig. 4). Tentatively it may be concluded that the pH of the sweat 
can less easily be changed by intake of acidifying substances than the urine pH.
F i g . 3
Mass-fragmentograms of the sweat sample VZ5. W ith the L.K.B. 9000 combined 
gaschromatograph-mass spectrometer the single ion m/e 91,.m /e 72 and m/e 58 is recorded. 
T he retention times found fór L-dimethyl- and L-methamphetamine are identical with 
those of the reference compounds.
Probably the sweat pH is for each person a typical function of the blood pH. 
Excretion of amphetamine-like compounds in human sweat is largely independ­
ent on sweat pH.
Extensive studies have been made with regard to the excretion of amphetamine 
and amphetamine-like compounds in the urine of a large number of human
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FlG. 4
Renal excretion rate of L-dimethylamphetamine and the metabolite L-m etham pheta- 
mine. Sweat concentration in ftg/ml of L-dimethylamphetamine and L-methamphetamine. 
Urine and sweat production, ürine and sweat pH , cumulative renal excretion.
T he drawn lines represent the L-dimethylamphetamine excretion rate in the urine and 
the concentration in the sweat ( A)- The dotted lines represent the metabolite L-m etham­
phetamine in urine and sweat ( A).
subjects (9). However, only recently has been shown that. the excretion in the 
urine and saliva parallels the bloodconcentration decay curves (11, 10). In this 
study it has been shown that the excretion curves of amphetamine in sweat 
follow the same pattern as that in the urine.
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A nalysis o f  h u m an  sw eat o r o f sw eat in th e  sh ir t  o f an  a th le te  im m ediate ly  
a fte r th e  a th le tic  pe rfo rm an ce  m ay b e  u sed .as  a  m eans o f d o p ing  contro l.
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